Encapsulation of Vitamin C by Glycerol-Derived Dendrimers, Their Interaction with Biomimetic Models of Stratum corneum and Their Cytotoxicity
-
Published:2022-11-18
Issue:22
Volume:27
Page:8022
-
ISSN:1420-3049
-
Container-title:Molecules
-
language:en
-
Short-container-title:Molecules
Author:
Bacha KatiaORCID, Chemotti Catherine, Monboisse Jean-Claude, Robert Anthony, Furlan Aurélien, Smeralda WillyORCID, Damblon Christian, Estager Julien, Brassart-Pasco SylvieORCID, Mbakidi Jean-Pierre, Pršić JelenaORCID, Bouquillon Sandrine, Deleu MagaliORCID
Abstract
Vitamin C is one of the most sensitive cosmetic active ingredients. To avoid its degradation, its encapsulation into biobased carriers such as dendrimers is one alternative of interest. In this work, we wanted to evaluate the potential of two biobased glycerodendrimer families (GlyceroDendrimers-Poly(AmidoAmine) (GD-PAMAMs) or GlyceroDendrimers-Poly(Propylene Imine) (GD-PPIs)) as a vitamin C carrier for topical application. The higher encapsulation capacity of GD-PAMAM-3 compared to commercial PAMAM-3 and different GD-PPIs, and its absence of cytotoxicity towards dermal cells, make it a good candidate. Investigation of its mechanism of action was done by using two kinds of biomimetic models of stratum corneum (SC), lipid monolayers and liposomes. GD-PAMAM-3 and VitC@GD-PAMAM-3 (GD-PAMAM-3 with encapsulated vitamin C) can both interact with the lipid representatives of the SC lipid matrix, whichever pH is considered. However, only pH 5.0 is suggested to be favorable to release vitamin C into the SC matrix. Their binding to SC-biomimetic liposomes revealed only a slight effect on membrane permeability in accordance with the absence of cytotoxicity but an increase in membrane rigidity, suggesting a reinforcement of the SC barrier property. Globally, our results suggest that the dendrimer GD-PAMAM-3 could be an efficient carrier for cosmetic applications.
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference66 articles.
1. Delivery of cancer therapies by synthetic and bio-inspired nanovectors;Briolay;Mol. Cancer,2021 2. Stecanella, L.A., Bitencourt, A.P.R., Vaz, G.R., Quarta, E., Silva, J.O.C., and Rossi, A. (2021). Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer. Pharmaceutics, 13. 3. Synthesis and in vitro antitumour activity of carboplatin analoguescontaining functional handles compatible for conjugation to drug delivery systems;Cantelli;Bioorg. Med. Chem. Lett.,2020 4. Drug Vectoring Systems to Target Drug Delivery Using Nanotechnologies;Curr. Nanomed.,2018 5. Deka Dey, A., Bigham, A., Esmaeili, Y., Ashrafizadeh, M., Moghaddam, F.D., Cheng Tan, S., Yousefiasl, S., Sharma, S., Cláudia Paiva-Santos, A., and Maleki, A. (2022). Seminars in Cancer Biology, Academic Press.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|